MedPath

Comparison of effect of Early switch over versus Late switchover from intravitreal anti VEGF injection to intravitreal dexamethasone in patient with Diabetic macular edema

Not Applicable
Conditions
Health Condition 1: H350- Background retinopathy and retinalvascular changes
Registration Number
CTRI/2024/04/065744
Lead Sponsor
dr sunil das
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosis of Diabetic macular edema

Patients who have taken atleast 1 intravitreal injection of Anti VEGF

Exclusion Criteria

Prio intravitrral dexamethasone injection

Active intraocular inflammation and infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean best corrected visual acuity at 1month 3months 6months 1yearTimepoint: Mean best corrected visual acuity
Secondary Outcome Measures
NameTimeMethod
Mean change in Central Retinal ThicknessTimepoint: 12months
© Copyright 2025. All Rights Reserved by MedPath